News & Analysis as of

Agricultural Sector Plant Based Products

Vicente LLP

Understanding ESG Requirements for Licensing Colorado Natural Medicine Businesses

Vicente LLP on

Aspiring psychedelic business licensees in Colorado now have clarification on the ESG criteria required for natural medicine license applications, as the Colorado Natural Medicine Division (NMD) has finalized the rules for...more

MoFo Life Sciences

An Insecure Future: Court Ruling Guts USDA Regs On Genetically Engineered Plants

MoFo Life Sciences on

In a decision that raises significant questions about the future oversight of genetically engineered (GE) plants in the United States, the U.S. District Court for the Northern District of California on Monday, December 2,...more

Morrison & Foerster LLP

Preparing for Investment (and Success) as an Early-Stage Alternative Protein Business

Our last two alerts in this series covered key considerations for early-stage companies in the alternative protein industry and provided an overview of financing in the alternative protein industry. This alert follows those...more

Morrison & Foerster LLP

U.S. Plant Variety Protection Office Lowers Burdens for Multinational Applications: Canadian and Japanese PBR Offices Now...

On Thursday, January 25, 2024, the U.S. Plant Variety Protection Office (U.S. PVPO) announced that the Plant Breeders’ Rights (PBR) Offices of Canada and Japan are now accepting Distinctness, Uniformity, and Stability (DUS)...more

Vicente LLP

A Potential Breakthrough for Psychedelic Treatments: Ninth Circuit Court Ruling on Psilocybin Rescheduling

Vicente LLP on

On October 27, 2023, the Ninth Circuit Court of Appeals, in Aggarwal v. DEA, held that the U.S. Drug Enforcement Agency (DEA) must reconsider its denial of a petition to transfer psilocybin, the active ingredient in “magic...more

Morrison & Foerster LLP

Financing Options for an Early Stage Company in the Alternative Protein Industry

Morrison & Foerster LLP on

This article is Part A of the fifth alert in our series of alerts focussed on the alternative protein industry. It provides an overview of financing options for players in the industry and specifically discusses information...more

Morrison & Foerster LLP

Alternative Protein Industry Series

This article is the first in a series through which we intend to explore the alternative protein industry and discuss legal considerations for companies and investors operating within it. Background- With an expanding...more

Seyfarth Shaw LLP

CBD is Everywhere – But Where Does the FDA Stand?

Seyfarth Shaw LLP on

Seyfarth Synopsis: CBD is “thriving” in the current regulatory environment, but is it doing so illegally? As former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb opined last week, “the CBD craze is...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide